J M Warnet

1.7k total citations · 1 hit paper
14 papers, 1.4k citations indexed

About

J M Warnet is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J M Warnet has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Epidemiology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J M Warnet's work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cardiovascular Function and Risk Factors (3 papers). J M Warnet is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Liver Disease Diagnosis and Treatment (7 papers) and Cardiovascular Function and Risk Factors (3 papers). J M Warnet collaborates with scholars based in France and Germany. J M Warnet's co-authors include Jean‐Roger Claude, G Rosselin, Annick Fontbonne, François Cambien, N Thibult, J L Richard, A Jacqueson, Pierre Ducimetière, J. L. Richard and Marie‐Aline Charles and has published in prestigious journals such as Circulation, American Journal of Epidemiology and Journal of Clinical Epidemiology.

In The Last Decade

J M Warnet

13 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes

1989 487 citations Annick Fontbonne, François Cambien et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J M Warnet France	12	981	432	350	278	216	14	1.4k
T Hopferwieser Austria	6	643 0.7×	422 1.0×	305 0.9×	196 0.7×	135 0.6×	11	1.1k
William L. Isley United States	23	1.0k 1.0×	454 1.1×	382 1.1×	212 0.8×	366 1.7×	51	1.8k
E Nikkilä Finland	19	757 0.8×	360 0.8×	446 1.3×	185 0.7×	151 0.7×	36	1.4k
N. J. Morrish United Kingdom	8	810 0.8×	459 1.1×	242 0.7×	213 0.8×	222 1.0×	10	1.4k
R.S. Elkeles United Kingdom	18	502 0.5×	251 0.6×	316 0.9×	120 0.4×	127 0.6×	55	1.1k
M Dobiášová Czechia	18	552 0.6×	252 0.6×	449 1.3×	202 0.7×	146 0.7×	55	1.1k
James W. Chu United States	14	1.1k 1.1×	427 1.0×	343 1.0×	525 1.9×	313 1.4×	27	2.0k
R. S. Elkeles United Kingdom	23	881 0.9×	481 1.1×	589 1.7×	153 0.6×	503 2.3×	72	1.9k
Raija Malmström Finland	13	567 0.6×	316 0.7×	316 0.9×	462 1.7×	170 0.8×	15	1.3k
R.J. Heine Netherlands	22	920 0.9×	256 0.6×	264 0.8×	246 0.9×	363 1.7×	40	1.6k

Countries citing papers authored by J M Warnet

Since Specialization

Citations

This map shows the geographic impact of J M Warnet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J M Warnet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J M Warnet more than expected).

Fields of papers citing papers by J M Warnet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J M Warnet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J M Warnet. The network helps show where J M Warnet may publish in the future.

Co-authorship network of co-authors of J M Warnet

This figure shows the co-authorship network connecting the top 25 collaborators of J M Warnet. A scholar is included among the top collaborators of J M Warnet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J M Warnet. J M Warnet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Charles, Marie‐Aline, Annick Fontbonne, N Thibult, et al.. (2001). High Plasma Nonesterified Fatty Acids Are Predictive of Cancer Mortality but Not of Coronary Heart Disease Mortality: Results from the Paris Prospective Study. American Journal of Epidemiology. 153(3). 292–298. 43 indexed citations

Balkau, Beverley, E Eschwège, L Papoz, et al.. (1993). Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status.. BMJ. 307(6899). 295–299. 95 indexed citations

Balkau, Beverley, et al.. (1992). Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjects. Diabetologia. 35(1). 39–44. 26 indexed citations

Balkau, Beverley, et al.. (1991). The high risk of death by alcohol related diseases in subjects diagnosed as diabetic and impaired glucose tolerant: The paris prospective study after 15 years of follow-up. Journal of Clinical Epidemiology. 44(6). 465–474. 53 indexed citations

Fontbonne, Annick, Marie‐Aline Charles, N Thibult, et al.. (1991). Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up. Diabetologia. 34(5). 356–361. 312 indexed citations

Fontbonne, Annick, François Cambien, J L Richard, et al.. (1989). Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia. 32(5). 300–304. 487 indexed citations breakdown →

Cambien, François, J M Warnet, É. Eschwège, et al.. (1987). Body mass, blood pressure, glucose, and lipids. Does plasma insulin explain their relationships?. Arteriosclerosis An Official Journal of the American Heart Association Inc. 7(2). 197–202. 116 indexed citations

Cambien, François, J M Warnet, A Jacqueson, et al.. (1987). Relation of parental history of early myocardial infarction to the level of apoprotein B in men.. Circulation. 76(2). 266–271. 29 indexed citations

Cambien, François, A Jacqueson, J L Richard, et al.. (1986). IS THE LEVEL OF SERUM TRIGLYCERIDE A SIGNIFICANT PREDICTOR OF CORONARY DEATH IN “NORMOCHOLESTEROLEMIC” SUBJECTS?. American Journal of Epidemiology. 124(4). 624–632. 129 indexed citations

10.

Jacqueson, A, et al.. (1983). High density lipoprotein cholesterol and alcohol consumption in a french male population. Atherosclerosis. 48(2). 131–138. 16 indexed citations

11.

Cambien, François, J. L. Richard, Pierre Ducimetière, J M Warnet, & Judith Kahn. (1981). The Paris Cardiovascular Risk Factor Prevention Trial. Effects of two years of intervention in a population of young men.. Journal of Epidemiology & Community Health. 35(2). 91–97. 17 indexed citations

12.

Donnadieu, M, et al.. (1976). THE LIVER AS A SOURCE OF SOMATOMEDIN. European Journal of Endocrinology. 83(2). 365–372. 21 indexed citations

13.

Rosselin, G, Jean‐Roger Claude, Eveline Eschwège, et al.. (1971). Diabetes survey plasma insulin during 0-2h oral glucose tolerance test systematically carried out in a professional group. Diabetologia. 7(1). 34–45. 11 indexed citations

14.

Claude, Jean‐Roger, Félix Corre, & J M Warnet. (1969). [Determination of triglycerides in biological media by a fluorometric semi-automatic method].. PubMed. 11(1). 16–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact